Free press releases distribution network?

Agency / Source: Frost & Sullivan

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award - Unique Platform in the Bone Graft Market
Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award


PRZOOM - /newswire/ - Mountain View, CA, United States, 2009/06/22 - Unique Platform in the Bone Graft Market.

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Based on its analysis of the bone graft market, Frost & Sullivan recognizes Bone Solutions, Inc. (BSI) with the North American Frost & Sullivan Award for Technology Leadership of the Year for its development of OsteoCrete™. The OsteoCrete™ is a revolutionary grafting material for attaching ligaments and tendons to bone and bone-to-bone. On May 21, 2009 OsteoCrete received FDA 510(k) clearance as a bone void filler for long bone and pelvis applications.

OsteoCrete™ is composed of magnesium oxide (Mg), monopotassium phosphate, and a small component of tricalcium phosphate. This compound provides an osteoconductive, biologic scaffold onto which new bone can form during the window of healing. The Mg gives the cement a powerful binder quality that theoretically allows it to resist tensile forces at time zero, thereby potentially limiting graft-tunnel motion. Several in vivo animal and bench test studies have shown OsteoCrete™ to have a peak tensile load to failure that is up to three times higher that of calcium-based bone cements in both bone-bone and tendon-bone attachments.

“BSI’s commercialization, following its FDA clearance, is the first solution under its magnesium technology platform for orthopedic surgeries and other orthobiologics applications,” says Frost & Sullivan Research Analyst Aarti Shetty. “This disruptive adhesive technology has lucrative potential in human markets, as it potentially represents the first compound that can attach bone to bone, as well as ligaments and tendons to bone.”

OsteoCrete™ makes use of this technology platform in humans as a bone void filler, and this platform could revolutionize sports medicine injury repair, as well as several key segments of orthopedics and orthobiologics.

Over the last decade, end users have increasingly accepted the clinical application of these bone fillers/cements as bone substitutes in trauma and orthopedic surgery. Scientists have intensively investigated Ca-phosphate compounds including tricalcium phosphates, Ca sulfates and hydroxyapatite.

Researchers are also exploring the potential of injectable Ca-based pastes as delivery vehicles for proteins such as bone morphogenetic protein (BMP) 2 for fractures. However, their slow absorption rate and non-adhesive qualities limit their utility to being carriers for other materials that may promote bone formation and providing a scaffold for bony ingrowth. Biomechanically, cements do not offer adhesive properties and are weak under tension.

“Increasing evidence shows that Mg-based implants promote bone formation during healing (osteoconduction), and may ultimately show in future FDA filings the ability of growing new bone (osteogenisis) and Mg-based alloys are being studied as orthopedic biomaterials,” notes Shetty. “Looking to the future, BSI is also investigating alternative new products based on its magnesium-oriented technology, as Mg-based bone void filler may be less prone to other complications associated with Ca-based biomaterials such as the activation of clotting.”

Owing to the application breadth, BSI has large, fragmented addressable markets, totaling $3 billion globally. The company is exploring licensing or joint venturing for various orthopedic applications, including trauma for synthetic bone grafts, sports medicine, extremities, maxillofacial/cranial, and dental.

Following its FDA 510 (k) clearance, BSI plans to complete a series of four additional 510(k) approvals as bone void filler for cranial applications, for maxillofacial applications, and for non-load bearing spine applications, as well as a bone anchor, to broaden its scope of product application. The company has already started implementing its plans in discussing marketing, distribution, and potential strategic relationships with key orthopedic companies.

“BSI's strategy is to follow new FDA clearances for its 510 (k) filings, and rapidly deploy its magnesium-oriented platform technology across a spectrum of surgical procedures such as anterior cruciate ligament (ACL)/rotator cuff/extremities, shoulder repair, cementless knee and hip, maxillofacial/cranial applications and dental implants,” observes Shetty. “BSI’s technology may supplement bio-absorbable screws, or fully replace screws and plates now used for major knee and shoulder surgeries, allowing for more rapid recoveries.”

Each year, Frost & Sullivan presents this award to the company that has demonstrated excellence in technology leadership within its industry. It has demonstrated technology leadership by excelling in all stages of the technology life cycle—incubation, adaptation, take-up, and maturity—to ensure a continuous flow of improvements. By innovating leading-edge concepts, the company has pioneered client applications.

Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for demonstrating outstanding achievement and superior performance in areas such as leadership, technological innovation, customer service, and strategic product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research in order to identify best practices in the industry.

About Bone Solutions, Inc.

Bone Solutions Inc. (‘BSI’) ( intends to establish its magnesium-based platform as the ‘one stop bone-, tendon- and ligament-injectable, biodegradable adhesive technology’ for surgeries at hospitals, clinics and other private surgical centers within the orthopedic industry. The Company believes it is revolutionizing a new solution for orthopedic surgeons for human uses with a magnesium-based platform that may attach—for the first time in orthopedic medical history—bone to bone, as well as ligaments and tendons to bone.

About Frost & Sullivan

Frost & Sullivan (, the Growth Partnership Company, enables clients to accelerate growth and achieve best in class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages over 45 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 35 offices on six continents.

Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Agency / Source: Frost & Sullivan


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker


Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

# # #
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!

Frost & Sullivan Selects Bone Solutions for Technology Leadership of the Year Award

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
Frost & Sullivan |
Contact: Jake Wengroff 
210.247.3806 jake.wengroff[.]
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Frost & Sullivan securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Press Releases From Frost & Sullivan / Company Profile

Read Medical Services/Equipment Most Recent Related Press Releases:

Frost & Sullivan Commends Influence Health for Constantly Evolving its Patient Engagement Products to Accelerate Market Transformation
Frost & Sullivan Awards Carestream Top Honors for OnSight 3D Extremity System
Sparta Systems Launches the Next-Generation Cloud Solution Stratas QMS
Koning Wins Accolades from Frost & Sullivan for the Impressive Innovation Behind its Groundbreaking KBCT Breast Imaging Device
Frost & Sullivan Awards ResMed for Developing S+ Advanced Sleep Tracking System
Sparta Systems Becomes First Quality Management Solutions Provider to Achieve EU-U.S. Privacy Shield Compliance
ZOLL Expands the Rescuer Experience at EMS World Expo
Agfa and GPMI Sign Distribution Agreement for Agfa’s Synthetic Paper Synaps
Frost & Sullivan Highlights iLine Microsystems for Developing a Microfluidics-Based Sophisticated POC Device for PT/INR Coagulation Testing
GE Healthcare’s Biosafe Announces Sefia Platform to Address Multiple Steps in Cell Therapy Production Process

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



Visit  NAKIVO, Inc.


  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today